PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
08-Aug-2024 Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb Evotec SE
08-Aug-2024 Kuros Biosciences Reports First Half of 2024 Results Kuros Biosciences AG
07-Aug-2024 Evotec SE reports first half-year 2024 results on 14 August 2024 Evotec SE
07-Aug-2024 Navigating the Neuro Products Market: What to Look for in a Manufacturer Taksa Pharmaceuticals
07-Aug-2024 Formycon invites to conference call on 2024 half-year results and announces participation in international investor conferences Formycon AG
06-Aug-2024 Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results Nyxoah SA.
06-Aug-2024 Evotec provides guidance update Evotec SE
06-Aug-2024 Evotec SE provides guidance update Evotec SE
06-Aug-2024 Medical Affairs Summit marcusevans
06-Aug-2024 Formycon AG increases its outlook for the 2024 fiscal year Formycon AG
06-Aug-2024 QUANTRO Therapeutics secures important Austrian research grant to accelerate development of cutting-edge platform QUANTRO Therapeutics GmbH
06-Aug-2024 Biotest increases sales in the first half of 2024 by 35% to Euro 372 million Biotest AG
06-Aug-2024 Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone ABIVAX
06-Aug-2024 Expansion of the Executive Committee and handover of the position of CFO Galenica AG
06-Aug-2024 Galenica achieves solid growth in a challenging market environment Galenica AG
05-Aug-2024 Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area Eckert & Ziegler SE
05-Aug-2024 Invitation: Straumann Group 2024 half-year results webcast Straumann Holding AG
05-Aug-2024 Medios expands „Advanced Therapies“ field and appoints Dr. Andreas Schmiede as Vice President Medios AG
05-Aug-2024 Davis Morgan Labs Unveils "How to Successfully Launch Your Monopoly Pharma Franchise: A Step-by-Step Guide" Davis Morgan Labs
05-Aug-2024 MorphoSys Completes Voluntary Delisting from the Frankfurt Stock Exchange and Nasdaq Global Market MorphoSys AG